| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.3M | +8.3% |
| Cost of Revenue | $8.2M | +4.2% |
| Gross Profit | $19.1M | +10.2% |
| R&D Expense | $7.3M | +26.5% |
| SG&A Expense | $29.7M | +2.2% |
| Operating Income | -$51.1M | -61.6% |
| Pre-tax Income | -$47.5M | -32.6% |
| Income Tax | -$557K | +58.2% |
| Net Income | -$47.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -45.8% |
| Accounts Receivable | $2.4M | +102.4% |
| Inventory | $5.1M | -1.3% |
| Current Assets | $81.8M | -18.1% |
| Total Assets | $207.4M | -18.1% |
| Current Liabilities | $9.3M | +3.3% |
| Total Liabilities | $11.7M | -11.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.6M | -47.9% |
| Capital Expenditures | $5.2M | +950.8% |
| Investing Cash Flow | $17.9M | +1032.1% |
| Financing Cash Flow | -$70K | — |
| Free Cash Flow | -$28.8M | -75.1% |
| -36.1% |
| EPS (Basic) | -$0.05 | -42.9% |
| EPS (Diluted) | -$0.05 | -42.9% |
| Stockholders' Equity |
| $195.7M |
| -18.5% |